detrusor overactivity – Patient Worthy

Botox is on Its Way to Become a New Therapeutic Option for Children with Neurogenic Detrusor Overactivity

Post author:Trudy Horsting
Post published:June 29, 2020
Post category:Cervical Dystonia Spina Bifida

Botox Botox was first approved as a treatment for strabismus and blepharospasm, rare eye conditions, in 1989. Now, it is approved for 11 different conditions including cervical dystonia, chronic migraines,…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More